Standard BioTools agrees to sell microfluidics business to Archimed
LAB•Standard BioTools agreed to sell its microfluidics business to Archimed. The deal is expected to close in about 30 days, and the business will continue operating as part of Standard BioTools until closing.
1. Sale agreement
Standard BioTools agreed to sell its microfluidics business to Archimed. The deal is expected to close in about 30 days; until then, the business will continue to operate as part of Standard BioTools.
